As an illustration, it has been demonstrated that prime-dose CsA—but not minimal dose CsA—straight inhibits the expression of NFATc1 and IL-two in human T cells from stimulated whole blood samples, assessed by circulation cytometry (23). Therefore, compared with other cytotoxic immune suppressors, CsA isn't going to eliminate the immune effector https://landenivhsc.gynoblog.com/29376193/the-basic-principles-of-eprenetapopt